Extending telomeres to extend the human healthspan
At Rejuvenation we're resetting a key mechanism of aging
We have a robust pipeline focused on aging and fatal diseases in which short telomeres have causal or major exacerbating roles. We are developing these programs in-house and through partnerships and out-licensing.
Our strategy is to make safe rapid telomere extension available as broadly and quickly as possible
Founder & CEO, Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Founder & COO, Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
VP of Development Operations, Founder of liver diagnostics company, Luminist (acquired by DiscernDx). Decade of drug and device development experience.
Helen M. Blau
Founder & Advisor, Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
Life Science Research Associate, MSc in Biotechnology.
Research Scientist, Postdoc at Stanford University on the proteomics of aging in the liver and brain, PhD in Biophysics at UT Southwestern on neurotransmitter release.
Research Fellow, MD, MSc, PhD, CTBS, Clinical and Preclinical Development at Boehringer Ingelheim and Gilead. Postdoc at Yale University on novel roles of ion transport proteins.
Robin E. Holbrook
Director of Finance and Administration, Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
Patient inquiries: email@example.com
General inquiries: firstname.lastname@example.org
Employment inquiries: email@example.com
Investor inquiries: firstname.lastname@example.org
Rejuvenation Technologies also provides our TeloAid line of reagents and nucleic acid compounds for use in scientific and medical research. Please contact email@example.com for orders meeting your specifications and needs.